Pancreatic Cancer Clinical Trials

Showing 541-560 of 1,185 trials

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

NCT03714555

This is an open-label Phase 2 Pilot study to evaluate Disulfiram + Copper Gluconate in patients metastatic pancreatic cancer whose CA-19-9 levels rise while receiving nab-paclitaxel (Abraxane) plus gemcitabine (Gemzar) or FOLFIRINOX or single-agent gemcitabine (Gemzar). Patient must have received a minimum of 8 weeks of treatment and have rising CA-19-9 levels in the absence of radiographic evidence of progression.

Metastatic Pancreatic Cancer

HonorHealth Research Institute1 participantsStarted Oct 2019

Scottsdale, Arizona, United States

UNKNOWNPhase 2

Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma

NCT05363007

Splenomegaly is common in advanced pancreatic ductal adenocarcinoma (PDAC). The spleen is an important source of immune suppressive cells and phagocytic cells and may mediate the accumulation of liposomal drugs and immunosuppression. In this study, spleen irradiation (SI) will be added to standard chemotherapy.

Metastatic Pancreatic Cancer

National Taiwan University Hospital60 participantsStarted May 2022

Tainan, Taiwan • Taipei, Taiwan

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma

Related Searches

A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors

MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis

High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors

Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer

Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping

Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion.

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)

Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma

Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma